Panion & Bf Biotech Inc. (TWSE: 1760)
Health Care · Pharmaceuticals · TW
NT$59.00
+0.68% today · -14.9% 1Y
Panion & Bf Biotech Inc. (TWSE: 1760) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $158.86M and employs 321 people.
Over the last twelve months the share price has lost 14.9%, trading between 57.90 and 76.40.
Tweenvest scores Panion & Bf Biotech Inc. across four factors: quality 77/100, value 80/100, growth 73/100, dividend 54/100. Its strongest factor is value.
1760 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $158.86M
- Revenue (TTM)
- $66.30M
- P/E
- 23.59
- EPS
- 2.50
- Dividend yield
- 3.39%
- Beta (5Y)
- -0.11
- 52-week high
- NT$76.40
- 52-week low
- NT$57.90
- Avg volume (3M)
- —
- Shares outstanding
- 85.74M
- Employees
- 321
- Next earnings
- —
About Panion & Bf Biotech Inc.
Panion & Bf Biotech Inc. is a biopharmaceutical firm operating in Taiwan, engaged in the production and distribution of a diverse range of pharmaceutical goods. Its offerings cater to several key therapeutic and wellness segments, including medical aesthetics, renal care, respiratory health, and gastrointestinal support. Beyond these, the company also provides oral medications, topical treatments, and an array of hygiene products like hand, mechanical, and skin disinfectants, alongside body lotions. Additionally, Panion & Bf Biotech supplies veterinary health solutions, notably surgical and dermatological prescriptions for animals. Established in 1976, the company maintains its corporate headquarters in Taipei, Taiwan.
- ISIN
- TW0001760007
- Founded
- 1976
- Listed since
- Dec 20, 2007
- Exchange
- Taiwan Stock Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.